Wintest
6721
Renascience
4889
CRE
3458
Abeja
5574
Reiwa Accounting Holdings
296A
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -2.87%31.04B | 4.80%126.44B | 6.45%28.53B | 7.22%34.76B | 1.25%31.2B | 4.37%31.96B | 2.21%120.65B | 0.41%26.8B | 2.94%32.42B | 3.12%30.82B |
Cost of revenue | -9.16%22.07B | 3.57%94.71B | 3.19%21.78B | 3.26%24.87B | 0.14%23.76B | 7.88%24.3B | 6.15%91.44B | 4.26%21.11B | 6.31%24.09B | 8.34%23.72B |
Gross profit | 17.11%8.97B | 8.64%31.74B | 18.52%6.75B | 18.66%9.89B | 4.96%7.45B | -5.40%7.66B | -8.45%29.21B | -11.71%5.69B | -5.70%8.33B | -11.18%7.09B |
Operating expense | -0.51%5.82B | 0.61%23.95B | 3.53%6.14B | 0.54%6B | -1.94%5.97B | 0.38%5.85B | 2.25%23.81B | 3.31%5.93B | 0.08%5.96B | 3.29%6.09B |
Staff costs | ---- | 1.70%5.87B | ---- | ---- | ---- | ---- | 4.21%5.77B | ---- | ---- | ---- |
Selling and administrative expenses | ---- | -0.35%8.72B | ---- | ---- | ---- | ---- | -1.14%8.75B | ---- | ---- | ---- |
-Selling and marketing expense | ---- | 1.57%4.8B | ---- | ---- | ---- | ---- | -3.14%4.72B | ---- | ---- | ---- |
-General and administrative expense | ---- | -2.60%3.93B | ---- | ---- | ---- | ---- | 1.31%4.03B | ---- | ---- | ---- |
Depreciation and amortization | ---- | -17.58%450M | ---- | ---- | ---- | ---- | -19.59%546M | ---- | ---- | ---- |
-Depreciation | ---- | -17.58%450M | ---- | ---- | ---- | ---- | -19.59%546M | ---- | ---- | ---- |
Other operating expenses | ---- | 1.99%8.92B | ---- | ---- | ---- | ---- | 6.39%8.74B | ---- | ---- | ---- |
Operating profit | 74.32%3.14B | 44.04%7.78B | 358.05%609M | 64.23%3.89B | 46.77%1.48B | -20.29%1.8B | -37.35%5.4B | -133.29%-236M | -17.67%2.37B | -51.96%1.01B |
Net non-operating interest income (expenses) | 13.89%-93M | 5.99%-424M | 5.45%-104M | 5.36%-106M | 7.02%-106M | 6.09%-108M | 2.59%-451M | 1.79%-110M | 1.75%-112M | 6.56%-114M |
Non-operating interest income | --0 | --0 | --0 | --0 | --0 | --0 | -88.89%2M | --0 | -80.00%1M | -75.00%1M |
Non-operating interest expense | -13.89%93M | -6.40%424M | -5.45%104M | -6.19%106M | -7.83%106M | -6.09%108M | -5.82%453M | -5.98%110M | -5.04%113M | -8.73%115M |
Net investment income | 21.71%342M | 40.92%520M | 1,957.14%144M | 16.67%35M | -16.67%60M | 8.08%281M | 8.53%369M | -91.95%7M | -78.10%30M | 453.85%72M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 0 | -150.00%-23M | 2,712.50%209M | -2,066.67%-65M | -530.23%-185M | 28.57%18M | 143.40%46M | -166.67%-8M | 50.00%-3M | 191.49%43M |
Less:Other special charges | ---- | -939.39%-686M | -7,550.00%-918M | 2,066.67%65M | 530.23%185M | -28.57%-18M | -162.26%-66M | -500.00%-12M | -50.00%3M | -191.49%-43M |
Less:Write off | ---- | 3,445.00%709M | ---- | ---- | ---- | ---- | --20M | ---- | ---- | ---- |
Other non-operating income (expenses) | 0.00%67M | 39.46%205M | -15.22%39M | 25.00%55M | 980.00%44M | 8.06%67M | -30.99%147M | 21.05%46M | -22.81%44M | -111.11%-5M |
Income before tax | 68.01%3.46B | 46.17%8.05B | 392.16%894M | 63.51%3.81B | 28.57%1.29B | -17.04%2.06B | -35.95%5.51B | -142.80%-306M | -21.06%2.33B | -49.50%1B |
Income tax | 76.60%996M | -6.44%1.34B | -285.51%-532M | 38.84%933M | 81.46%372M | -18.26%564M | -39.88%1.43B | -192.00%-138M | -21.86%672M | -61.90%205M |
Net income | 64.82%2.46B | 64.63%6.72B | 944.38%1.43B | 73.39%2.88B | 14.95%915M | -16.57%1.5B | -34.46%4.08B | -129.96%-169M | -20.72%1.66B | -44.88%796M |
Net income continuous operations | 64.77%2.47B | 64.59%6.72B | 948.81%1.43B | 73.49%2.88B | 14.95%915M | -16.56%1.5B | -34.45%4.08B | -129.73%-168M | -20.73%1.66B | -44.88%796M |
Noncontrolling interests | 0 | 0 | 0 | 0 | ||||||
Net income attributable to the company | 64.82%2.46B | 64.63%6.72B | 944.38%1.43B | 73.39%2.88B | 14.95%915M | -16.57%1.5B | -34.46%4.08B | -129.96%-169M | -20.72%1.66B | -44.88%796M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 64.82%2.46B | 64.63%6.72B | 944.38%1.43B | 73.39%2.88B | 14.95%915M | -16.57%1.5B | -34.46%4.08B | -129.96%-169M | -20.72%1.66B | -44.88%796M |
Gross dividend payment | ||||||||||
Basic earnings per share | 64.78%203.98 | 67.30%555.89 | 1,078.13%118.06 | 76.52%238.35 | 17.62%75.69 | -14.61%123.79 | -32.49%332.28 | -126.03%-12.07 | -18.16%135.03 | -43.39%64.35 |
Diluted earnings per share | 64.78%203.98 | 67.30%555.89 | 944.25%118.06 | 76.50%238.324 | 17.62%75.69 | -14.61%123.79 | -32.49%332.28 | -130.67%-13.984 | -18.14%135.03 | -43.39%64.35 |
Dividend per share | 0 | 14.81%62 | 22.22%33 | 0 | 7.41%29 | 0 | 8.00%54 | 8.00%27 | 0 | 8.00%27 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |